These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 14600027)

  • 21. Taxol inhibits progression of congenital polycystic kidney disease.
    Woo DD; Miao SY; Pelayo JC; Woolf AS
    Nature; 1994 Apr; 368(6473):750-3. PubMed ID: 7908721
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cell polarity in human renal cystic disease.
    Carone FA; Nakamura S; Caputo M; Bacallao R; Nelson WJ; Kanwar YS
    Lab Invest; 1994 May; 70(5):648-55. PubMed ID: 8196361
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of polycystic kidney disease in juvenile cystic kidney mice: insights into pathogenesis, ciliary abnormalities, and common features with human disease.
    Smith LA; Bukanov NO; Husson H; Russo RJ; Barry TC; Taylor AL; Beier DR; Ibraghimov-Beskrovnaya O
    J Am Soc Nephrol; 2006 Oct; 17(10):2821-31. PubMed ID: 16928806
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular and cellular pathophysiology of autosomal recessive polycystic kidney disease (ARPKD).
    Sweeney WE; Avner ED
    Cell Tissue Res; 2006 Dec; 326(3):671-85. PubMed ID: 16767405
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Renal expression of a transforming growth factor-alpha transgene accelerates the progression of inherited, slowly progressive polycystic kidney disease in the mouse.
    Gattone VH; Kuenstler KA; Lindemann GW; Lu X; Cowley BD; Rankin CA; Calvet JP
    J Lab Clin Med; 1996 Feb; 127(2):214-22. PubMed ID: 8636651
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-lasting arrest of murine polycystic kidney disease with CDK inhibitor roscovitine.
    Bukanov NO; Smith LA; Klinger KW; Ledbetter SR; Ibraghimov-Beskrovnaya O
    Nature; 2006 Dec; 444(7121):949-52. PubMed ID: 17122773
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aquaporin-11 knockout mice and polycystic kidney disease animals share a common mechanism of cyst formation.
    Okada S; Misaka T; Tanaka Y; Matsumoto I; Ishibashi K; Sasaki S; Abe K
    FASEB J; 2008 Oct; 22(10):3672-84. PubMed ID: 18606867
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Murine models of polycystic kidney disease.
    Schieren G; Pey R; Bach J; Hafner M; Gretz N
    Nephrol Dial Transplant; 1996; 11 Suppl 6():38-45. PubMed ID: 9044327
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Kidney-specific inactivation of the KIF3A subunit of kinesin-II inhibits renal ciliogenesis and produces polycystic kidney disease.
    Lin F; Hiesberger T; Cordes K; Sinclair AM; Goldstein LS; Somlo S; Igarashi P
    Proc Natl Acad Sci U S A; 2003 Apr; 100(9):5286-91. PubMed ID: 12672950
    [TBL] [Abstract][Full Text] [Related]  

  • 30. C-myc as an inducer of polycystic kidney disease in transgenic mice.
    Trudel M; D'Agati V; Costantini F
    Kidney Int; 1991 Apr; 39(4):665-71. PubMed ID: 1646908
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transcriptome analysis of a rat PKD model: Importance of genes involved in extracellular matrix metabolism.
    Riera M; Burtey S; Fontés M
    Kidney Int; 2006 May; 69(9):1558-63. PubMed ID: 16541020
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A hypomorphic mutation in the mouse laminin alpha5 gene causes polycystic kidney disease.
    Shannon MB; Patton BL; Harvey SJ; Miner JH
    J Am Soc Nephrol; 2006 Jul; 17(7):1913-22. PubMed ID: 16790509
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A hereditary model of slowly progressive polycystic kidney disease in the mouse.
    Takahashi H; Calvet JP; Dittemore-Hoover D; Yoshida K; Grantham JJ; Gattone VH
    J Am Soc Nephrol; 1991 Jan; 1(7):980-9. PubMed ID: 1883968
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Loss of GM3 synthase gene, but not sphingosine kinase 1, is protective against murine nephronophthisis-related polycystic kidney disease.
    Natoli TA; Husson H; Rogers KA; Smith LA; Wang B; Budman Y; Bukanov NO; Ledbetter SR; Klinger KW; Leonard JP; Ibraghimov-Beskrovnaya O
    Hum Mol Genet; 2012 Aug; 21(15):3397-407. PubMed ID: 22563011
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evidence that two phenotypically distinct mouse PKD mutations, bpk and jcpk, are allelic.
    Guay-Woodford LM; Bryda EC; Christine B; Lindsey JR; Collier WR; Avner ED; D'Eustachio P; Flaherty L
    Kidney Int; 1996 Oct; 50(4):1158-65. PubMed ID: 8887273
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fish mesonephric model of polycystic kidney disease in medaka (Oryzias latipes) pc mutant.
    Mochizuki E; Fukuta K; Tada T; Harada T; Watanabe N; Matsuo S; Hashimoto H; Ozato K; Wakamatsu Y
    Kidney Int; 2005 Jul; 68(1):23-34. PubMed ID: 15954893
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Overexpression of innate immune response genes in a model of recessive polycystic kidney disease.
    Mrug M; Zhou J; Woo Y; Cui X; Szalai AJ; Novak J; Churchill GA; Guay-Woodford LM
    Kidney Int; 2008 Jan; 73(1):63-76. PubMed ID: 17960140
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of interstitial inflammation in the pathogenesis of polycystic kidney disease.
    Ta MH; Harris DC; Rangan GK
    Nephrology (Carlton); 2013 May; 18(5):317-30. PubMed ID: 23448509
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic localization of interacting modifiers affecting severity in a murine model of polycystic kidney disease.
    Kuida S; Beier DR
    Genome Res; 2000 Jan; 10(1):49-54. PubMed ID: 10645949
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Recent advances in molecular pathogenesis and polycystic kidney disease treatment].
    Covic M; Covic M
    Rev Med Chir Soc Med Nat Iasi; 2009; 113(1):13-22. PubMed ID: 21495291
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.